Found: 225
Select item for more details and to access through your institution.
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK/T cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 18, p. 16279, doi. 10.1007/s00432-023-05385-8
- By:
- Publication type:
- Article
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 11907, doi. 10.1007/s00432-023-04993-8
- By:
- Publication type:
- Article
Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma.
- Published in:
- Maxillofacial Plastic & Reconstructive Surgery, 2017, v. 39, n. 1, p. 1, doi. 10.1186/s40902-016-0099-4
- By:
- Publication type:
- Article
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 92, doi. 10.1093/jjco/hyy177
- By:
- Publication type:
- Article
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00948-5
- By:
- Publication type:
- Article
Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 6, p. 773, doi. 10.1007/s12185-013-1335-7
- By:
- Publication type:
- Article
Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 5, p. 640, doi. 10.1007/s12185-013-1312-1
- By:
- Publication type:
- Article
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 5, p. 634, doi. 10.1007/s12185-013-1311-2
- By:
- Publication type:
- Article
Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.
- Published in:
- 2006
- By:
- Publication type:
- commentary
Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Spontaneous pneumothorax developed in patients with bronchiolitis obliterans after unrelated hematopoietic stem cell transplantation: case report and review of the literature.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Structural and functional insights into the B30.2/SPRY domain.
- Published in:
- EMBO Journal, 2006, v. 25, n. 6, p. 1353, doi. 10.1038/sj.emboj.7600994
- By:
- Publication type:
- Article
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02227-0
- By:
- Publication type:
- Article
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 4969, doi. 10.1007/s00520-021-06017-y
- By:
- Publication type:
- Article
Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study).
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01368-2
- By:
- Publication type:
- Article
Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1281782
- By:
- Publication type:
- Article
Oral supplementation with p‐coumaric acid protects mice against diabetes‐associated spontaneous destruction of periodontal tissue.
- Published in:
- Journal of Periodontal Research, 2019, v. 54, n. 6, p. 690, doi. 10.1111/jre.12678
- By:
- Publication type:
- Article
A Novel Function of Interleukin-10 Promoting Self-Renewal of Hematopoietic Stem Cells.
- Published in:
- Stem Cells, 2007, v. 25, n. 7, p. 1814, doi. 10.1634/stemcells.2007-0002
- By:
- Publication type:
- Article
Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial‐unfit patients and subsequent therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 101, doi. 10.1111/bjh.17071
- By:
- Publication type:
- Article
Successful prevention and screening strategies for COVID‐19: focus on patients with haematologic diseases.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. e33, doi. 10.1111/bjh.16818
- By:
- Publication type:
- Article
Predictive impact of circulating microRNA‐193a‐5p on early relapse after autologous stem cell transplantation in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. 518, doi. 10.1111/bjh.16413
- By:
- Publication type:
- Article
Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 860, doi. 10.1111/bjh.16257
- By:
- Publication type:
- Article
Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 777, doi. 10.1111/bjh.12820
- By:
- Publication type:
- Article
Influence of ex vivo purging with Clini MACS CD34<sup>+</sup> selection on outcome after autologous stem cell transplantation in non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 4, p. 555, doi. 10.1111/bjh.12664
- By:
- Publication type:
- Article
Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA‐matched sibling donor.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1441, doi. 10.1002/ajh.26320
- By:
- Publication type:
- Article
Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies.
- Published in:
- Hepatology Research, 2016, v. 46, n. 7, p. 657, doi. 10.1111/hepr.12603
- By:
- Publication type:
- Article
Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. N.PAG, doi. 10.1186/s40164-020-00178-y
- By:
- Publication type:
- Article
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913).
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 956, doi. 10.4143/crt.2024.074
- By:
- Publication type:
- Article
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 693, doi. 10.4143/crt.2022.952
- By:
- Publication type:
- Article
The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-020-02087-7
- By:
- Publication type:
- Article
Prognostic value of low muscle mass at the 12<sup>th</sup> thoracic vertebral level in multiple myeloma treated with transplantation: CAREMM-2101 study.
- Published in:
- Diagnostic & Interventional Radiology, 2023, v. 29, n. 4, p. 596, doi. 10.4274/dir.2023.232097
- By:
- Publication type:
- Article
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2365, doi. 10.1007/s00277-024-05615-0
- By:
- Publication type:
- Article
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1217, doi. 10.1007/s00277-022-04776-0
- By:
- Publication type:
- Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
- By:
- Publication type:
- Article
Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death.
- Published in:
- 2020
- By:
- Publication type:
- journal article